300111.SZ
向日葵
SZSE · Healthcare · C 制造业 · CN
CNY 2.91
−3.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 253.9M | 271.5M | 330.4M | 338.4M | 335.9M |
| Cost of Revenue | 196.8M | 214.7M | 255.7M | 254.5M | 239.6M |
| Gross Profit | 57.1M | 56.8M | 74.6M | 83.9M | 96.3M |
| Operating Expenses | |||||
| R&D Expense | 8.8M | 10.8M | 19.1M | 19.1M | 14.2M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 35.8M | 34.1M | 33.1M | 45.8M | 31.5M |
| Selling & Marketing Expense | 16.8M | 17.7M | 27.7M | 41.1M | 52.5M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 56.2M | 55.2M | 65.2M | 98.1M | 91.3M |
| Cost and Expenses | 253.0M | 269.9M | 321.0M | 352.6M | 330.9M |
| Operating Income (EBIT) | (8.2M) | (4.7M) | 12.4M | 26.0M | 5.9M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (9.1M) | (5.4M) | 12.6M | 24.9M | 4.6M |
| Income Tax Expense | (755.9K) | (1.4M) | (783.9K) | 989.9K | 71.2K |
| Bottom Line | |||||
| Net Income | (9.5M) | (4.4M) | 7.8M | 21.7M | (1.1M) |
| Earnings from Cont. Ops | (8.3M) | (4.0M) | 13.4M | 23.9M | 4.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (9.5M) | (4.4M) | 7.8M | 21.7M | (1.1M) |
| Per Share | |||||
| Basic EPS | (CN¥0.01) | (CN¥0.00) | CN¥0.01 | CN¥0.02 | (CN¥0.00) |
| Diluted EPS | (CN¥0.01) | (CN¥0.00) | CN¥0.01 | CN¥0.02 | (CN¥0.00) |
| Revenue Per Share | CN¥0.20 | CN¥0.19 | CN¥0.25 | CN¥0.26 | CN¥0.29 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.5B | 1.3B | 1.3B | 1.1B |
| Diluted Shares Outstanding | 1.3B | 1.5B | 1.3B | 1.3B | 1.1B |
| Profitability Metrics | |||||
| EBITDA | — | 11.3M | 29.7M | 43.5M | 22.0M |
| D&A | — | 15.9M | 17.4M | 17.5M | 16.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026